Longboard Pharmaceuticals CMO Sells Shares
| Reporter Name | Kaye Randall |
| Relationship | CMO |
| Type | Sell |
| Amount | $527,318 |
| SEC Filing | Form 4 |
Longboard Pharmaceuticals' CMO, Kaye Randall, sold 16,666 shares of common stock on September 16, 2024, for a total of $527,318. The sales were conducted at weighted average prices ranging from $30.886 to $34.0359. Following these transactions, Randall directly owns 17,920 shares of the company. The sales were executed under a Rule 10b5-1 trading plan.
SEC Filing: Longboard Pharmaceuticals, Inc. [ LBPH ] - Form 4 - Sep. 16, 2024